Fig. 2

Number of clinical trials based on DNA repair alterations, including MMR deficiency. A total of 256 studies have been conducted on several different tumor types. Among these, only 11 studies involved patients with a diagnosis of breast cancer. None of them included HR+ breast cancers. HR+, hormone receptor-positive